16.91
price down icon0.06%   -0.01
after-market Handel nachbörslich: 16.96 0.05 +0.30%
loading
Schlusskurs vom Vortag:
$16.92
Offen:
$17
24-Stunden-Volumen:
248.20K
Relative Volume:
11.39
Marktkapitalisierung:
$700.98M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+0.00%
1M Leistung:
+0.00%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
Value
$15.16
$17.56
1-Wochen-Bereich:
Value
$15.00
$18.84
52-Wochen-Spanne:
Value
$15.00
$18.84

Maplight Therapeutics Inc Stock (MPLT) Company Profile

Name
Firmenname
Maplight Therapeutics Inc
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
0
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
MPLT's Discussions on Twitter

Vergleichen Sie MPLT mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
MPLT
Maplight Therapeutics Inc
16.91 700.98M 0 0 0 0.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
426.00 109.11B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
642.25 68.50B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
434.07 60.25B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
826.28 50.39B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
186.23 40.44B 447.02M -1.18B -868.57M -6.1812

Maplight Therapeutics Inc Aktie (MPLT) Neueste Nachrichten

pulisher
Nov 02, 2025

Long term debt to total assets ratio of MapLight Therapeutics, Inc. – BOATS:MPLT - TradingView

Nov 02, 2025
pulisher
Nov 02, 2025

MapLight Therapeutics, Inc. Cash Flow – BOATS:MPLT - TradingView

Nov 02, 2025
pulisher
Nov 01, 2025

MapLight Therapeutics, Inc. (MPLT) options chain - Yahoo! Finance UK

Nov 01, 2025
pulisher
Nov 01, 2025

Sergey Brin Nonprofit Gets $261 Million Lift in MapLight IPO - MSN

Nov 01, 2025
pulisher
Oct 31, 2025

MapLight Therapeutics, Inc. (MPLT) Stock Major Holders - Yahoo! Finance Canada

Oct 31, 2025
pulisher
Oct 31, 2025

Finance Watch: MapLight Brings US Biopharma IPO Tally To 11 In 2025 - Citeline News & Insights

Oct 31, 2025
pulisher
Oct 31, 2025

MapLight Therapeutics Closes Successful IPO and Private Placement - MSN

Oct 31, 2025
pulisher
Oct 30, 2025

Major Investment Alert: A S Novo’s Multi-Million Dollar Bet on MapLight Therapeutics! - TipRanks

Oct 30, 2025
pulisher
Oct 30, 2025

Drug developer Evommune to go public next week, following MapLight's successful IPO - The Business Journals

Oct 30, 2025
pulisher
Oct 30, 2025

MapLight Therapeutics completes $296 million IPO on nasdaq - Investing.com

Oct 30, 2025
pulisher
Oct 29, 2025

Catalyst4, Inc. Makes a Major Move with a Massive Stock Purchase in MapLight Therapeutics! - TipRanks

Oct 29, 2025
pulisher
Oct 29, 2025

MapLight Therapeutics, Inc. (MPLT) Latest Stock News & Headlines - Yahoo! Finance Canada

Oct 29, 2025
pulisher
Oct 29, 2025

MapLight Therapeutics, Inc. (MPLT) Stock Forum & Discussion - Yahoo! Finance Canada

Oct 29, 2025
pulisher
Oct 29, 2025

MapLight Therapeutics, Inc. (MPLT) Interactive Stock Chart - Yahoo! Finance Canada

Oct 29, 2025
pulisher
Oct 29, 2025

MapLight Therapeutics completes $296 million IPO on nasdaq By Investing.com - Investing.com Nigeria

Oct 29, 2025
pulisher
Oct 29, 2025

MapLight Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares - The Manila Times

Oct 29, 2025
pulisher
Oct 29, 2025

MapLight Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares - Benzinga

Oct 29, 2025
pulisher
Oct 28, 2025

Total equity of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView

Oct 28, 2025
pulisher
Oct 28, 2025

Total liabilities of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView

Oct 28, 2025
pulisher
Oct 28, 2025

Diluted earnings per share (diluted EPS) of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView

Oct 28, 2025
pulisher
Oct 28, 2025

MapLight Therapeutics, Inc. Revenue Breakdown – NASDAQ:MPLT - TradingView

Oct 28, 2025
pulisher
Oct 28, 2025

Total liabilities & shareholders' equities of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView

Oct 28, 2025
pulisher
Oct 28, 2025

Diluted net income available to common stockholders of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView

Oct 28, 2025
pulisher
Oct 28, 2025

Operating income of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView

Oct 28, 2025
pulisher
Oct 28, 2025

Net debt of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView

Oct 28, 2025
pulisher
Oct 28, 2025

Total debt of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView

Oct 28, 2025
pulisher
Oct 28, 2025

Inventory turnover of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView

Oct 28, 2025
pulisher
Oct 28, 2025

Operating expenses (excl. COGS) of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView

Oct 28, 2025
pulisher
Oct 28, 2025

Taxes of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView

Oct 28, 2025
pulisher
Oct 28, 2025

MapLight Therapeutics, Inc. Financial Statements – NASDAQ:MPLT - TradingView

Oct 28, 2025
pulisher
Oct 28, 2025

Total revenue of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView

Oct 28, 2025
pulisher
Oct 28, 2025

Total operating expenses of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView

Oct 28, 2025
pulisher
Oct 28, 2025

Gross profit of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView

Oct 28, 2025
pulisher
Oct 28, 2025

Net income of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView

Oct 28, 2025
pulisher
Oct 28, 2025

Cost of goods sold of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView

Oct 28, 2025
pulisher
Oct 28, 2025

Non-operating income (total) of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView

Oct 28, 2025
pulisher
Oct 28, 2025

Pretax income of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView

Oct 28, 2025
pulisher
Oct 28, 2025

After tax other income/expense of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView

Oct 28, 2025
pulisher
Oct 28, 2025

Diluted shares outstanding of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView

Oct 28, 2025
pulisher
Oct 28, 2025

MapLight Therapeutics, Inc. Earnings and Revenue – NASDAQ:MPLT - TradingView

Oct 28, 2025
pulisher
Oct 28, 2025

Dilution adjustment of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView

Oct 28, 2025
pulisher
Oct 28, 2025

Price to cash flow ratio of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView

Oct 28, 2025
pulisher
Oct 28, 2025

EBITDA margin % of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView

Oct 28, 2025
pulisher
Oct 28, 2025

MapLight Therapeutics, Inc. Balance Sheet – NASDAQ:MPLT - TradingView

Oct 28, 2025
pulisher
Oct 28, 2025

Non-controlling/minority interest of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView

Oct 28, 2025
pulisher
Oct 28, 2025

Quick ratio of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView

Oct 28, 2025
pulisher
Oct 28, 2025

Muscarinic path still charting as Maplight IPO gets $258M - BioWorld MedTech

Oct 28, 2025
pulisher
Oct 28, 2025

MapLight Therapeutics, Inc. Income Statement – NASDAQ:MPLT - TradingView

Oct 28, 2025
pulisher
Oct 28, 2025

Net margin % of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView

Oct 28, 2025
pulisher
Oct 28, 2025

MapLight Therapeutics, Inc. Statistics – NASDAQ:MPLT - TradingView

Oct 28, 2025
pulisher
Oct 28, 2025

MapLight Therapeutics, Inc. (MPLT) Valuation Measures & Financial Statistics - Yahoo! Finance Canada

Oct 28, 2025

Finanzdaten der Maplight Therapeutics Inc-Aktie (MPLT)

Es liegen keine Finanzdaten für Maplight Therapeutics Inc (MPLT) vor. Überprüfen Sie andere Aktien für weitere Informationen.

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$37.30
price down icon 0.64%
$28.71
price up icon 0.35%
$101.57
price up icon 8.65%
$103.95
price up icon 0.04%
biotechnology ONC
$311.86
price up icon 0.44%
$186.23
price down icon 1.78%
Kapitalisierung:     |  Volumen (24h):